Brintellix Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing Brand Resources

Full Prescribing Info

Description

Each film-coated tablet contains 5 mg Vortioxetine (as 6.355 mg Vortioxetine hydrobromide).
Each film-coated tablet contains 10 mg Vortioxetine (as 12.710 mg Vortioxetine hydrobromide).
Each film-coated tablet contains 15 mg Vortioxetine (as 19.065 mg Vortioxetine hydrobromide).
Excipients/Inactive Ingredients: 5 mg: Tablet core: Mannitol, Microcystalline cellulose, Hydroxypropylcellulose, Sodium starch glycolate (type A), Magnesium stearate.
Tablet coating: Hypromellose, Macrogol 400, Titanium dioxide (E171), Iron oxide red (E172).
10 mg tablets:Tablet core: Mannitol, Microcystalline cellulose, Hydroxypropylcellulose, Sodium starch glycolate (type A), Magnesium stearate.
Tablet coating: Hypromellose, Macrogol 400, Titanium dioxide (E171), Iron oxide yellow (E172).
15 mg tablets: Tablet core: Mannitol, Microcystalline cellulose, Hydroxypropylcellulose, Sodium starch glycolate (type A), Magnesium stearate.
Tablet coating: Hypromellose, Macrogol 400, Titanium dioxide (E171), Iron oxide red (E172), Iron oxide yellow (E172).

vortioxetine

Manufacturer:

Lundbeck

Distributor:

Metro Drug